Published in Appl Radiat Isot on January 08, 2011
High-yield synthesis of the terminal 188Re triple bond N multiple bond from generator-produced [188ReO4](-). Nucl Med Biol (2003) 1.30
Is PET always an advantage versus planar and SPECT imaging? Eur J Nucl Med Mol Imaging (2008) 1.15
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Nucl Med Biol (2008) 1.02
99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats. J Nucl Med (2004) 1.00
Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res (2004) 0.90
Synthesis and characterization of fac-[M(CO)3(P)(OO)] and cis-trans-[M(CO)2(P)2(OO)] complexes (M = Re, (99m)Tc) with acetylacetone and curcumin as OO donor bidentate ligands. Inorg Chem (2013) 0.90
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties. J Nucl Med (2003) 0.88
Radioiodination of new EGFR inhibitors as potential SPECT agents for molecular imaging of breast cancer. Bioorg Med Chem (2007) 0.88
Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals. J Med Chem (2010) 0.88
Synthesis, characterization, and biological evaluation of M(I)(CO)3(NNO) complexes (M = Re, 99mTc) conjugated to 2-(4-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals. J Med Chem (2006) 0.87
Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD. Nucl Med Rev Cent East Eur (2004) 0.84
The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues. Peptides (2008) 0.84
Curcumin as the OO bidentate ligand in "2 + 1" complexes with the [M(CO)3]+ (M = Re, 99mTc) tricarbonyl core for radiodiagnostic applications. Inorg Chem (2011) 0.84
Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity. Biochem Biophys Res Commun (2005) 0.84
High-Resolution NMR Spectroscopy of the beta-Amyloid(1-28) Fibril Typical for Alzheimer's Disease. Angew Chem Int Ed Engl (2001) 0.81
Whole-body biodistribution and radiation dosimetry of the new cardiac tracer 99mTc-N-DBODC. J Nucl Med (2008) 0.81
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma. Nucl Med Commun (2004) 0.81
Chemistry of the strong electrophilic metal fragment [(99)Tc(N)(PXP)](2+) (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules. J Am Chem Soc (2002) 0.80
Structural assessment and biological evaluation of two N3S bombesin derivatives. J Med Chem (2009) 0.80
Mixed tridentate π -donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals. Curr Radiopharm (2013) 0.79
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma. Nucl Med Biol (2010) 0.79
Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging. Eur J Med Chem (2009) 0.78
Structural study by NMR of an oxorhenium-RGD decapeptide complex for application in radiotherapy. Inorg Chem (2004) 0.78
Radiolabeled nano-peptides show specificity for an animal model of human PC3 prostate cancer cells. Clinics (Sao Paulo) (2011) 0.78
Rhenium and technetium complexes bearing quinazoline derivatives: progress towards a 99mTc biomarker for EGFR-TK imaging. Dalton Trans (2008) 0.78
Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators. Nucl Med Biol (2010) 0.77
Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium. J Nucl Med (2003) 0.77
Rhenium(V) and technetium(V) nitrido complexes with mixed tridentate π-donor and monodentate π-acceptor ligands. Inorg Chem (2012) 0.77
Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease. Biochem Biophys Res Commun (2006) 0.77
Neovascularization after ischemic injury: evaluation with ⁹⁹(m)Tc-HYNIC-RGD. Acta Cir Bras (2011) 0.77
A variation in the component separation technique that preserves linea semilunaris: a study in cadavers and a clinical case. J Plast Reconstr Aesthet Surg (2009) 0.77
Oleuropein, an anti-oxidant polyphenol constituent of olive promotes α-secretase cleavage of the amyloid precursor protein (AβPP). Cell Mol Neurobiol (2012) 0.76
Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites. Drug Discov Today (2013) 0.76
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors. Bioconjug Chem (2003) 0.76
Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response. J Neurooncol (2007) 0.76
Detection of interactions of the beta-amyloid peptide with small molecules employing transferred NOEs. J Pept Sci (2009) 0.75
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand). Inorg Chem (2004) 0.75
Synthesis and characterization of novel 99gTc(V) and Re(V) complexes with water-soluble tetraaza diamido dipyridino ligands: single-crystal X-ray structural investigations of mono- and dinuclear complexes. Inorg Chem (2003) 0.75
Rhenium(I) Tricarbonyl Complexes with (2-Hydroxyphenyl)diphenylphosphine as PO Bidentate Ligand. Inorg Chem (2017) 0.75
Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies. Eur J Med Chem (2007) 0.75
Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the (99m)Tc(CO)3(+) core. Bioorg Med Chem (2013) 0.75
In vitro binding and in vivo biodistribution studies of the neuroprotective peptide humanin using [125I]humanin derivatives. Peptides (2009) 0.75
Convenient route leading to neutral fac-M(CO)3(NNO) complexes (M = Re, 99mTc) coupled to amine pharmacophores. Inorg Chem (2008) 0.75
Size and specificity of radiopharmaceuticals for sentinel lymph node detection. Acta Radiol (2011) 0.75
Labeling of fatty acid ligands with the strong electrophilic metal fragment [99mTc(N)(PNP)]2+ (PNP=diphosphane ligand). Bioconjug Chem (2008) 0.75
Relevance of micrometastases detected by reverse transcriptase-polymerase chain reaction for melanoma recurrence: systematic review and meta-analysis. Sao Paulo Med J (2003) 0.75
Synthesis and characterization of novel oxotechnetium (99Tc and 99mTc) and oxorhenium complexes from the 2,2'-bipyridine (NN)/thiol (S) mixed-ligand system. Inorg Chem (2003) 0.75
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals. Nucl Med Biol (2010) 0.75
Injection site radioactivity of (99m)Tc-labeled mannosylated dextran for sentinel lymph node mapping. Mol Pharm (2014) 0.75
Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection. Cancer Biother Radiopharm (2013) 0.75
New oxorhenium(V) complexes from the widely used diaminedithiol (DADT) ligand system. Inorg Chem (2002) 0.75
Solid-phase synthesis of a peptide derivative of thymosin alpha1 and initial studies on its (99m)Tc-radiolabelling. Chem Biol Drug Des (2007) 0.75
Synthesis and characterization of novel "3 + 2" oxorhenium complexes, ReO[SNO][NN]. Inorg Chem (2006) 0.75
Studies toward the biological efficacy of (99m)Tc-labeled dextran-cysteine-mannose ([(99m)Tc(CO)(3)]DCM20) for sentinel lymph node detection. Cancer Biother Radiopharm (2012) 0.75
Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents. J Inorg Biochem (2003) 0.75
Combining dose and injection volume for good performance of a specific radiopharmaceutical for sentinel node detection. Nucl Med Biol (2011) 0.75
Influence of colloid particle profile on sentinel lymph node uptake. Nucl Med Biol (2009) 0.75
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules. Bioconjug Chem (2004) 0.75
Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives. Inorg Chem (2006) 0.75
Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit morphine's rewarding effect in rats. Psychopharmacology (Berl) (2014) 0.75
Complexes of an alpha thymosin derivative with ¹⁸⁵/¹⁸⁷Re and (⁹⁹m)Tc: structural analysis and initial biological evaluation. Chem Biol Drug Des (2012) 0.75